Plasma high density lipoproteins phospholipds as an indirect indicator of their cholesterol efflux capacity — new suspected atherosclerosis risk factor

   
Tereshkina Yu.A.1 , Kostryukova L.V.1, Torkhovskaya T.I.1, Khudoklinova Yu.Yu.1, Tikhonova E.G.1

1. Institute of Biomedical Chemistry, Moscow, Russia
Section: Review
DOI: 10.18097/PBMC20216702119      PubMed Id: 33860768
Year: 2021  Volume: 67  Issue: 2  Pages: 119-129
High density lipoproteins (HDL) are a unique natural structure, protecting the body from the development of atherosclerotic vascular lesions and cardiovascular diseases due to this ability to remove cholesterol from cells. Plasma HDL level estimated by their cholesterol content, is a common lipid parameter, and its decrease is considered as an established atherosclerosis risk factor. However, a number of studies have shown the absence of positive clinical effects after drug-induced increase in HDL cholesterol. There is increasing evidence that not only HDL concentration, but also HDL properties, considered in this review are important. Many studies showed the decrease of HDL cholesterol efflux capacity in patients with coronary heart diseases and its association with disease severity. Some authors consider a decrease of this HDL capacity as a new additional risk factor of atherosclerosis. The review summarizes existing information on various protein and lipid components of HDL with a primary emphasis on the HDL. Special attention is paid to correlation between the HDL cholesterol efflux capacity and HDL phospholipids and the ratio “phospholipids/free cholesterol”. The accumulated information indicates importance of evaluation in the HDL fraction not only in terms of their cholesterol, but also phospholipids. In addition to the traditionally used lipid criteria, this would provide more comprehensive information about the activity of the reverse cholesterol transport process in the body and could contribute to the targeted correction of the detected disorders.
Download PDF:  
Keywords: high density lipoproteins, phospholipids, cholesterol removal, cholesterol efflux capacity, apoprotein A1
Citation:

Tereshkina, Yu. A., Kostryukova, L. V., Torkhovskaya, T. I., Khudoklinova, Yu. Yu., Tikhonova, E. G. (2021). Plasma high density lipoproteins phospholipds as an indirect indicator of their cholesterol efflux capacity — new suspected atherosclerosis risk factor. Biomeditsinskaya Khimiya, 67(2), 119-129.
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)